Ivan Rangelov ACMA, CGMA is a seasoned finance professional with extensive experience in the pharmaceutical industry, currently serving as CFO for the Balkans Cluster at AstraZeneca since September 2012. Previous roles at AstraZeneca include Head of Finance for Bulgaria and Serbia, FP&A Analyst for Central and Eastern Europe, and Finance Manager for Business Development, where significant financial analysis and strategic deal support were provided, including a $250 million in-licensing and a $215 million divestment. Ivan also partnered with the Nordic-Baltic Marketing Company in oncology, focusing on financial planning and analysis across four countries. Earlier experience includes a finance internship at Procter & Gamble and a leadership role as Chief Editor for the "UYIFS Market Report" at the University of York Investment & Finance Society. Ivan holds a BSc in Economics and Finance from the University of York and is a member of the Chartered Institute of Management Accountants.